Radiationtreatment planning for Cervical and Head andNeck cancer using machine
Not Applicable
Not yet recruiting
- Conditions
- Health Condition 1: C539- Malignant neoplasm of cervix uteri, unspecifiedHealth Condition 2: C14- Malignant neoplasm of other and ill-defined sites in the lip, oral cavity and pharynx
- Registration Number
- CTRI/2023/05/053119
- Lead Sponsor
- Medical Research Council University College London
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. Consecutive patients at each participating centre with histologically confirmed head and neck cancers of the oropharynx, larynx, hypopharynx and nasopharynx (Stage I-III) that have given consent for primary curative radiotherapy.
2. Consecutive histologically confirmed primary cervical cancer patients (Stage IB-IIIB including pelvic node positive) that have given consent for radical radiotherapy.
Exclusion Criteria
1. Patients requiring radiotherapy after curative or de-bulking surgery.
2. Patients aged under 18.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Overall treatment plan acceptability <br/ ><br>Plan acceptability between the manual plan and that generated by automated treatment planningTimepoint: 4 years
- Secondary Outcome Measures
Name Time Method Cost effectiveness <br/ ><br>Timepoint: 4 years;Time and resource savings <br/ ><br> <br/ ><br>Timepoint: 4 years